本次公开发行情况               发行价（元/股）                                                                                                                                                                         13.99                                                    停牌前收盘价（元/股）    14.4

                               发行市盈率                                                                                                                                                                              24.49倍                                                  停牌前总市值（亿元）     17.45

                               定价方式                                                                                                                                                                                询价                                                     募集资金总额（万元）     9581.75

                               是否向战略投资者配售                                                                                                                                                                    一名战略投资者获配14.9万股，约占本次发行总规模的2.18%                                 

财务表现                       营业收入（亿元）                                                                                                                                                                        6.02                                                     5.5                      5.58

（2017年-2019年）                                                                                                                                                                                                                                                                                            

                               归母净利润（万元）                                                                                                                                                                      7933.83                                                  7224.75                  9116.93

                               毛利率                                                                                                                                                                                  83.05%                                                   80.96%                   80.11%

本次募资用途                   云南生物谷大健康产业园项目和补充流动资金                                                                                                                                                                                                                                      

主营业务简介                   公司是目前国内从事灯盏花系列药品生产企业中产销规模、品种结构、自主知识产权等方面均处于领先地位的制药企业，是国内灯盏花药品领域的龙头企业，目前在灯盏花类口服制剂市场中处于主导地位。